Next Article in Journal
A First-in-Human Trial to Evaluate the Safety and Immunogenicity of a G Protein-Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18–45 Years of Age
Previous Article in Journal
Knowledge and Attitudes towards Human Papillomavirus Vaccination (HPV) among Healthcare Providers Involved in the Governmental Free HPV Vaccination Program in Shenzhen, Southern China
 
 
vaccines-logo
Article Menu

Article Menu

Article

Article Versions Notes

Vaccines 2023, 11(5), 998; https://doi.org/10.3390/vaccines11050998
Action Date Notes Link
article pdf uploaded. 18 May 2023 14:09 CEST Version of Record https://www.mdpi.com/2076-393X/11/5/998/pdf-vor
article xml file uploaded 20 May 2023 14:19 CEST Original file -
article xml uploaded. 20 May 2023 14:19 CEST Update -
article pdf uploaded. 20 May 2023 14:19 CEST Updated version of record https://www.mdpi.com/2076-393X/11/5/998/pdf-vor
article html file updated 20 May 2023 14:20 CEST Original file -
article xml file uploaded 20 May 2023 15:56 CEST Update -
article xml uploaded. 20 May 2023 15:56 CEST Update -
article pdf uploaded. 20 May 2023 15:56 CEST Updated version of record https://www.mdpi.com/2076-393X/11/5/998/pdf-vor
article html file updated 20 May 2023 15:58 CEST Update -
article xml file uploaded 23 May 2023 07:41 CEST Update -
article xml uploaded. 23 May 2023 07:41 CEST Update https://www.mdpi.com/2076-393X/11/5/998/xml
article pdf uploaded. 23 May 2023 07:41 CEST Updated version of record https://www.mdpi.com/2076-393X/11/5/998/pdf
article html file updated 23 May 2023 07:42 CEST Update https://www.mdpi.com/2076-393X/11/5/998/html
Back to TopTop